Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

To characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient responses.

NCT Number	NCT07139990
Lead Sponsor	University of Texas Southwestern Medical Center
Conditions	Small Cell Lung Cancer Extensive Stage, Brain Metastases, Solid Tumor, Adult
Enrollment	45 participants
Start Date	2025-10-28
Primary Completion	2028-09-01 (estimated)
Study Completion	2030-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-11-10